Protein tyrosine phosphatase controls breast cancer invasion through the expression of matrix metalloproteinase-9
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The expression of matrix metalloproteinases (MMPs) produced by cancer cells has been associated with the high potential of metastasis in several human carcinomas, including breast cancer. Several pieces of evidence demonstrate that protein tyrosine phosphatases (PTP) have functions that promote cell migration and metastasis in breast cancer. We analyzed whether PTP inhibitor might control breast cancer invasion through MMP expression. Herein, we investigate the effect of 4-hydroxy-3,3-dimethyl-2H benzo[g]indole-2,5(3H)-dione (BVT948), a novel PTP inhibitor, on 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced MMP-9 expression and cell invasion in MCF-7cells. The expression of MMP-9 and cell invasion increased after TPA treatment, whereas TPA-induced MMP-9 expression and cell invasion were decreased by BVT948 pretreatment. Also, BVT948suppressed NF-κB activation in TPA-treated MCF-7 cells. However, BVT948 didn’t block TPA-induced AP-1 activation in MCF-7 cells. Our results suggest that the PTP inhibitor blocks breast cancer invasion via suppression of the expression of MMP-9.
Abstract
The expression of matrix metalloproteinases (MMPs) produced by cancer cells has been associated with the high potential of metastasis in several human carcinomas, including breast cancer. Several pieces of evidence demonstrate that protein tyrosine phosphatases (PTP) have functions that promote cell migration and metastasis in breast cancer. We analyzed whether PTP inhibitor might control breast cancer invasion through MMP expression. Herein, we investigate the effect of 4-hydroxy-3,3-dimethyl-2H benzo[g]indole-2,5(3H)-dione (BVT948), a novel PTP inhibitor, on 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced MMP-9 expression and cell invasion in MCF-7cells. The expression of MMP-9 and cell invasion increased after TPA treatment, whereas TPA-induced MMP-9 expression and cell invasion were decreased by BVT948 pretreatment. Also, BVT948suppressed NF-κB activation in TPA-treated MCF-7 cells. However, BVT948 didn’t block TPA-induced AP-1 activation in MCF-7 cells. Our results suggest that the PTP inhibitor blocks breast cancer invasion via suppression of the expression of MMP-9.
참고문헌 (34)
- Osborne, C. K., "Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice", Cancer Res, 45, pp.584~590 (1985)
- Kohrmann, A., "Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature", BMC Cancer, 9, pp.188~ (2009)
- Page-McCaw, A., "Matrix metalloproteinases and the regulation of tissue remodelling", Nat. Rev. Mol. Cell Biol, 8, pp.221~233 (2007)
- McGowan, P. M., "Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database", Ann. Oncol, 19, pp.1566~1572 (2008)
- Price, J. E., "Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice", Cancer Res, 50, pp.717~721 (1990)
- Himelstein, B. P., "Metalloproteinases in tumor progression: the contribution of MMP-9", Invasion Metastasis, 14, pp.246~258 (1994)
- Zucker, S., "Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment", Oncogene, 19, pp.6642~6650 (2000)
- Genersch, E., "Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways", J. Cell Sci, 113(Pt 23), pp.4319~4330 (2000)
- Jallal, B., "The receptor-like protein-tyrosine phosphatase DEP-1 is constitutively associated with a 64-kDa protein serine", threonine kinase, 1997, pp.272, 12158~12163
- Wang, F. M., "SHP-2 promoting migration and metastasis of MCF-7 with loss of E-cadherin, dephosphorylation of FAK and secretion of MMP-9 induced by IL-1beta in vivo and in vitro", Breast Cancer Res. Treat, 89, pp.5~14 (2005)
- Han, S. S., "Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells", J. Biochem. Mol. Biol, 35, pp.337~342 (2002)
- Chambers, A. F., "Changing views of the role of matrix metalloproteinases in metastasis", J. Natl. Cancer Inst, 89, pp.1260~1270 (1997)
- Stetler-Stevenson, W. G., "Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic", Semin. Cancer Biol, 7, pp.147~154 (1996)
- Deryugina, E. I, "Matrix metalloproteinases and tumor metastasis", Cancer Metastasis Rev, 25, pp.9~34 (2006)
- Soulsby, M., "Physiological signaling specificity by protein tyrosine phosphatases", Physiology (Bethesda), 24, pp.281~289 (2009)
- Zhang, Z. Y., "Functional studies of protein tyrosine phosphatases with chemical approaches", Biochim. Biophys. Acta, 1754, pp.100~107 (2005)
- Freiss, G., "Protein tyrosine phosphatases and breast cancer", Crit. Rev. Oncol. Hematol, 52, pp.9~17 (2004)
- Wiener, J. R., "Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression", J. Natl. Cancer Inst, 86, pp.372~378 (1994)
- Aceto, N., "Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop", Nat. Med, 18, pp.529~537 (2012)
- Pellikainen, J. M., "Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis", Clin. Cancer Res, 10, pp.7621~7628 (2004)
- Scorilas, A., "Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients", Br. J. Cancer, 84, pp.1488~1496 (2001)
- Cho, H. J., "Ascofuranone suppresses PMA-mediated matrix metalloproteinase- 9 gene activation through the Ras", Raf, ERK- and Ap1-dependent mechanisms, pp.Carcinogenesis, 2007[DOI]
- Kajanne, R., "EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways", J. Cell Physiol, 212, pp.489~497 (2007)
- Srivastava, A. K., "Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway", J. Biol. Chem, 282, pp.35113~35124 (2007)
- Newton, A. C., "Protein kinase C: structure, function, and regulation", J. Biol. Chem, 270, pp.28495~28498 (1995)
- Datta, R., "Phorbol ester-induced generation of reactive oxygen species is protein kinase cbeta -dependent and required for SAPK activation", J. Biol. Chem, 275, pp.41000~41003 (2000)
- Schlingemann, J., "Profile of gene expression induced by the tumour promotor TPA in murine epithelial cells", Int. J. Cancer, 104, pp.699~708 (2003)
- Jemal, A., "Cancer statistics, 2005", CA. Cancer J. Clin, 55, pp.10~30 (2005)
- Chung, T. W., "Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism", FASEB J, 18, pp.1670~1681 (2004)
- Eberhardt, W., "Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways", J. Immunol, 165, pp.5788~5797 (2000)
- Fridman, R., "Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)", Cancer Res, 55, pp.2548~2555 (1995)
- Yamamoto, Y., "Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer", J. Clin. Invest, 107, pp.135~142 (2001)
- Thanos, D., "NF-kappa B: a lesson in family values", Cell, 80, pp.529~532 (1995)
- Noh, E. M., "Cordycepin inhibits TPA-induced matrix metalloproteinase-9 expression by suppressing the MAPK", AP-1 pathway in MCF-7 human breast cancer cells, 2010, pp.25, 255~260
